US3373741A - Plastic splint - Google Patents
Plastic splint Download PDFInfo
- Publication number
- US3373741A US3373741A US441389A US44138965A US3373741A US 3373741 A US3373741 A US 3373741A US 441389 A US441389 A US 441389A US 44138965 A US44138965 A US 44138965A US 3373741 A US3373741 A US 3373741A
- Authority
- US
- United States
- Prior art keywords
- splint
- envelope
- compartment
- resin
- compartments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920003023 plastic Polymers 0.000 title description 4
- 239000004033 plastic Substances 0.000 title description 4
- 229920005989 resin Polymers 0.000 description 23
- 239000011347 resin Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 21
- 239000003054 catalyst Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000002243 precursor Substances 0.000 description 12
- 239000006260 foam Substances 0.000 description 10
- -1 polypropylene Polymers 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 7
- 239000004604 Blowing Agent Substances 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 229920001225 polyester resin Polymers 0.000 description 6
- 229920001228 polyisocyanate Polymers 0.000 description 6
- 239000005056 polyisocyanate Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229920005830 Polyurethane Foam Polymers 0.000 description 5
- 229920000647 polyepoxide Polymers 0.000 description 5
- 239000004645 polyester resin Substances 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003077 polyols Chemical class 0.000 description 5
- 239000011496 polyurethane foam Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003822 epoxy resin Substances 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 150000002513 isocyanates Chemical class 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 3
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- VGHSXKTVMPXHNG-UHFFFAOYSA-N 1,3-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC(N=C=O)=C1 VGHSXKTVMPXHNG-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- WFUGQJXVXHBTEM-UHFFFAOYSA-N 2-hydroperoxy-2-(2-hydroperoxybutan-2-ylperoxy)butane Chemical compound CCC(C)(OO)OOC(C)(CC)OO WFUGQJXVXHBTEM-UHFFFAOYSA-N 0.000 description 1
- QZWKEPYTBWZJJA-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine-4,4'-diisocyanate Chemical compound C1=C(N=C=O)C(OC)=CC(C=2C=C(OC)C(N=C=O)=CC=2)=C1 QZWKEPYTBWZJJA-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 208000016593 Knee injury Diseases 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- 206010061225 Limb injury Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 229920000538 Poly[(phenyl isocyanate)-co-formaldehyde] Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical class CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002483 hydrogen compounds Chemical class 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- GIWKOZXJDKMGQC-UHFFFAOYSA-L lead(2+);naphthalene-2-carboxylate Chemical compound [Pb+2].C1=CC=CC2=CC(C(=O)[O-])=CC=C21.C1=CC=CC2=CC(C(=O)[O-])=CC=C21 GIWKOZXJDKMGQC-UHFFFAOYSA-L 0.000 description 1
- 239000004850 liquid epoxy resins (LERs) Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- SGGOJYZMTYGPCH-UHFFFAOYSA-L manganese(2+);naphthalene-2-carboxylate Chemical compound [Mn+2].C1=CC=CC2=CC(C(=O)[O-])=CC=C21.C1=CC=CC2=CC(C(=O)[O-])=CC=C21 SGGOJYZMTYGPCH-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- GEMHFKXPOCTAIP-UHFFFAOYSA-N n,n-dimethyl-n'-phenylcarbamimidoyl chloride Chemical compound CN(C)C(Cl)=NC1=CC=CC=C1 GEMHFKXPOCTAIP-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000088 plastic resin Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
- 229920006337 unsaturated polyester resin Polymers 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/04—Plaster of Paris bandages; Other stiffening bandages
Definitions
- splints are required to render the injured member immobile while the patient is being transferred to a hospital or other place for the necessary medical treatment.
- Splints also are used in the treatment of injuries such as sprains and dislocations in which a permanent cast is not required.
- the splint be light weight and compact. It is also desirable that the splint be applicable under adverse conditions of light and Weather.
- the splint should be capable of bearing a load so that the injured party may, after having the splint applied, leave the scene of the injury under his own power.
- the emergency splints presently used by the Army are generally either basswood splints or wire ladder splints. Both of these splints are bulky and must be heavily padded before use.
- the splint of this invention before application, is a unitary, flexible structure capable of being folded or rolled into a compact package and weighs approximately 0.9 pound.
- FIG. 1 is a perspective view of one embodiment of the invention
- FIG. 2 is a perspective view of the splint of the invention used in the treatment of a knee injury
- FIG. 3 is a perspective view of an embodiment of the invention employing a foam forming resin
- FIG. 4 is a perspective view of a splint for use on an injured jaw.
- FIG. 5 is a perspective view, partly cut away, of a packaged splint.
- the splint comprises a closed envelope containing at least two separate and distinct materials maintained separately, the materials when mixed being capable of forming a cured plastic resin composition.
- blowing agents and reinforcice ing means may also be incorporated in the envelope when needed.
- the essential characteristic to be considered in choosing the material used for the envelope is that it be insoluble in, non-reactive with and non-permeable to the materials used to form the cured resin. Suitable materials consist of most of the commercially available packaging films. Polystyrene and Pliofilm, however, which tend to be soluble in urethane systems containing tolylene diisocyanate therefore should not be used with such systems.
- the films can be heat scalable or capable of adhesive bonding and may either be single layers or laminated. Films which can be used either alone or in lamination are cellophane, cellulose acetate, polyvinylidene chloride, polyvinyl chloride, polypropylene, polyethylene and polyesters.
- a particularly good laminate consists of oriented polyestenpolyvinylidene chloride-polyethylene since the individual layers provide distinct advantages in the film.
- the polyester supplies toughness to resist tearing when the envelope is kneaded; the polyvinylidene chloride provides a water vapor barrier to protect water-sensitive isocyanate components and the polyethylene permits heat sealing.
- Aluminum foil also can be incorporated in a laminate to reduce water vapor permeability.
- the resin systems usable in the invention are quite varied. The essential criteria in their choice being that they cure to form a hardened solid upon the mixture of the separate components of the system without the application of heat. Foam systems that do not require the application of heat from an external source to accomplish blowing are usable in certain embodiments of the invention. Broadly, polyester, epoxy and polyurethane resin systems have been found to be particularly effective in this invention.
- the precursors of the cured resin are maintained physically separated in individual compartments in the splint envelope until the splint is to be formed at which time they are mixed, formed to shape and allowed to cure.
- the precursors may comprise the basic materials from which the cured resins are formed or they may be prepolymer or partial prepolymer systems.
- one compartment contains the uncured resin and a promoter, if necessary, and the other compartment could contain the catalyst.
- the uncured resin contains the uncured resin and the other compartment the curing agent.
- polyurethane foam systems one compartment contains a polyisocyanate and the other compartment contains a polyol resin, a blowing agent, a surfactant and catalyst.
- a prepolymer system is one in which the polyisocyanate and polyol are permitted to react in advance, with the polyisocyanate being present in excess in the product.
- This product is in the first compartment and the second compartment contains blowing agent, surfactant and catalyst.
- the amount of material in the second compartment is very small, being in the order of 1-10 parts of the mixture to parts prepolymer and permits the second compartment to be in the form of a capsule within the prepolymer compartment.
- a quasi or partial prepolymer system is similar to the prepolymer system except that only part of the polyol is reacted with the polyisocyanate to form the product in the first compartment and the second compartment contains polyol resin in addition to the materials of the prepolymer system.
- Polyester resins usable in this invention are those unsaturated polyester resins generally based on dibasic acids or anhydrides and dihydric alcohols which are capable a of crosslinking with vinylic monomers to form thermoset materials.
- suitable dibasic acids and anhydrides include maleic anhydride, phthalic anhydride, adipic acid, succinic acid and fumaric acid.
- Typical dihydric alcohols include ethylene, propylene, diethylene and dipropylene glycols. Polyhydroxyl alcohols such as glycerol and pentaerythritol can be used to introduce branching in the polyester chains.
- Monomers added to the resins which serve to reduce their viscosities and which are reactants in crosslinking of the resin include styrene, methyl methacrylate, diallyl phthalate and triallyl cyanurate.
- the type of resins defined above form the first component of a polyester system.
- Catalysts or initiators are used to actuate the crosslinking process through a free radical mechanism which involves the opening of the double bonds of the polyester chain and/or the monomer.
- Typical catalysts include peroxides such as benzoyl and lauroyl peroxide and hydroperoxides such as cumene and tertbutyl hydroperoxide and methylethylketone peroxide.
- Accelerators are used to promote release of free radicals and include metallic salts such as cobalt and manganese naphthenate, anilines such as diethyl and methyl aniline and mercaptans such as dodecyl mercaptan and mercaptoethanol.
- metallic salts such as cobalt and manganese naphthenate, anilines such as diethyl and methyl aniline and mercaptans such as dodecyl mercaptan and mercaptoethanol.
- the common epoxy resins are produced by the reaction of epoxy compounds with dihydro phenols, for example reacting epichlorodydrin with bisphenol A.
- liquid resins can be used, commercial examples of which are Epon 815 and 828 available from Shell Chemical Corporation and ERL 2795 available from Union Carbide.
- Epon 815 and 828 available from Shell Chemical Corporation and ERL 2795 available from Union Carbide.
- These resins are contained in one compartment and the curing agent or catalyst which may be amines, anhydrides or acids is in the second compartment.
- catalysts such as the polyfunctional aliphatic amines which cause rapid reaction, are required: examples of which are diethylene triamine and diethylamino propylamine.
- polyisocyanates useful in this application include 2,4-tolylene diisocyanate, 2,6-tolylene diisocyanate and mixtures of these isomers; p,p-diphenylmethane diisocyanate; m-phenylene diisocyanate; 1,5-naphthalene diisocyanate; hexamethyiene diisocyanate; dianisidine diisocyanate; polymethylene polyphenyl isocyanate; and diphenylmethane 4,4'-diisocyanate.
- Polyol or polyhydroxy compounds usable in the above systems include ethylene and propylene oxide adducts of polyfunctional active hydrogen compounds such as glycerine, sorbitol, trimethylolpropane, ethylene diamine, sucrose, etc., and generally referred to as polyethers.
- polyfunctional active hydrogen compounds such as glycerine, sorbitol, trimethylolpropane, ethylene diamine, sucrose, etc.
- polyethers generally referred to as polyethers.
- Another class of polyhydroxy compounds usable in the above systems are the hydroxyl terminated polyesters made by the esterification of polybasic acids with polyhydric alcohols.
- Blowing agents useful in this invention include water, which reacts with the isocyanate producing carbon dioxide, and other materials which generate a gas when mixed.
- Catalysts useful in these reactions include amines, particularly tertiary amines, e.g., N-methyl morpholine, triethyl amine, triethyl diamine (l,4-diazobicyclo-(2,2,2)- octane): organometallic compounds are likewise useful as catalysts, e.g., stannous octoate, dibutyltin dilaurate, lead naphthenate, cobalt naphthenate, tributyl in methacrylate.
- amines particularly tertiary amines, e.g., N-methyl morpholine, triethyl amine, triethyl diamine (l,4-diazobicyclo-(2,2,2)- octane): organometallic compounds are likewise useful as catalysts, e.g., stannous octoate, dibutyltin dil
- catalysts are known to the urethane foam industry and can be usefully employed in this application, e.g., organotin and tertiary amine combinations. Concentrations of these catalysts ranging between .1 and percent can be used, and this concentration may be varied to vary the reaction time.
- Useful surfactants include organo silicon compounds such as dimethyl polysiloxane and polyalkylene ether copolymers. Commercial products used include Union Carbide Corporations L-520, L53l, General Electric Corportions XI -1066 and SF-1034 and Dow Cornings 113.
- Polyurethane foam materials can be formed using these processes in a wide range of foam densities.
- Foam densities useful in this invention range from 4 to pounds per cubic foot.
- the material should be chosen so that the resin cures within a time suitable for the condition under which the splint is to be used.
- a rapid cure is essential and polyester or polyurethane systems that cure within 10 minutes are desirable.
- epoxy systems which have cure times in the order of hours, are suitable.
- one embodiment of the invention consists of a closed flexible envelope 1, formed from a laminate of 3 mil polyethylene and 1 mil mylar heat sealed around the edge having two compartments 2 and 3 formed at one end thereof.
- the compartments may be formed by a weak heat seal across the width of the envelope or by a weak adhesive bond or by means which pinch off an area across the width of the envelope.
- the preferred embodiment employs split resilient cylinder separators 4 and 5 which engage folds 6 and 7 of the envelope formed around cylinders and 51.
- Each compartment contains a precursor of a cured polyester resin system or of a cured epoxy resin system.
- the other portion of the envelope contains, coextensive therewith, a reinforcing mat 8.
- the mat is preferably made of 4 layers of woven fiberglass but other woven, knitted or matted textiles such as nylon, Dacron, cotton or Orlon may be used.
- the lower portion of the envelope has secured thereto thick flexible pad 9 which serves as padding to prevent irritation of the patient and also serves as insulation to protect the patent from the heat liberated during the curing process.
- Pad 9 can, for example, be made from A" flexible polyurethane foam adhesively bonded to the envelope by an adhesive on the foam.
- the separation between compartments 2 and 3 is removed by breaking the bond forming the separation or by removing separator 4 and the precursors in the two compartments are mixed thoroughly. After mixing is completed, the remaining separator 5 is removed and the contents worked uniformly into the remaining section of envelope 1 to impregnate mat 8 with the mixture. After the mat 8 has been impregnated with the resin, the split is placed in contact with the injured member, with the pad 9 contacting the body, and formed to the desired shape. The splint is then fastened in place by means of straps 10 as shown in FIG. 2.
- Suitable precursor compositions for a polyester resin system are set forth below:
- Epon curing agent T-1 g 50 Both components are available from Shell Chemical Corporation, Epon 815 being a liquid epoxy resin with a viscosity of about 700 centipoise and an epoxide equivalent of 175-195 and the T-l curing agent being an aliphatic polyamine. Cure was sufiicient to yield a weight bearing splint after 4 hours.
- the splint package used when a foam resin system is employed differs from that already described basically in that the mat 8 is not incorporated into the envelope.
- the envelope 1 has two compartments 2 and 3 formed at one end thereof by separators 4 and 5, each compartment containing a precursor of the foamed resin.
- the pad 9 is secured to envelope 1 up to the edge of compartment 3.
- the pad is equal in length to the whole envelope and that portion coextensive with compartments 2 and 3 has a strippable sheet 12 adhered thereto.
- the precursors are mixed as described above until the mixture takes on a whitish appearance and there is a noticeable evolution of heat.
- the other separator is then removed and the foaming resin worked uniformly through the envelope 1.
- the backing 12 is removed and pad 9 is adhered to the portion of the envelope that previously formed compartments 2 and 3.
- the splint is now ready for application and is placed in contact with the injured member, shaped and fastened as described above.
- Suitable precursor compositions, a polyurethane foam system are as follows:
- Isofoam 15W gm- 113 Stannous octoate mg 9 Triethylene diamine mg 9
- the Isofoam materials were obtained from the Isocyanate Products Co. and the above mixture yielded a weight bearing splint with a foam density of 18 pound/ft. six minutes after mixing of the precursors.
- FIG. 4 a splint package for a jaw injury is illustrated.
- the envelope 21 is formed into the shape shown with the central opening 22 heat sealed around the edges.
- a foam pad 23 of the same configuration as envelope 21 is adhered to one surface of the envelope 21.
- the envelope 21 contains a liquid prepolymer 24 having an excess of isocyanate and a blowing agent, catalyst, surfactant mixture is contained within rupturable capsule 25,
- the capsule can be formed of the same material as envelope 1. In use the capsule 25 is ruptured, the contents mixed with the prepolymer 24 until the mixture turns white and heat is evolved. The mixture is distributed evenly throughout the envelope and then applied with the subjects jaw in the central opening 22, formed to shape and then held in place with adhesive tape or tied by straps.
- envelopes Before curing the splint, envelopes can be rolled into a compact cylinder and packaged in a tubular container 30 together with the adhesive or other type of straps 11 used to fasten the splints as shown in FIG. 5.
- a splint package comprising a flexible sealed envelope having a flexible pad attached to one face thereof substantially coextensive therewith, the interior of said envelope being divided into at least two compartments by removable separating means, a first compartment containing a first material and a second compartment containing a second material, said first and second materials being precursors of a cured resin system and which, when mixed, will cure without the application of external heat.
- the splint package of claim 1 wherein the interior of said envelope is divided into three compartments, the third compartment containing, coextensive therewith, flexible reinforcing means and wherein said first and second materials are precursors of cured resin systems selected from the group consisting of polyester resins and epoxy resins.
- first and second materials are precursors of a foamed resin system and one of said materials contains a blowing agent.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
March 19, 1968 J. T. HILL ETAL 3,373,741
I PLASTIC SPLINT Filed March 19, 1965 2 Sheets-Sheet l Fla. 5
)Awuis T \\\LL DONALD [2, \MGENFTO 250 LEQNAQD QE EEZ M. MAQ6ETL5 fig ATTORNEY March 19, 1968 J. "r. HILL ETAL 3,373,741
PLASTIC SPLINT Filed-march l9. 1965 2 Sheets-Shee 2 JAM res T DONALD Q. \N 6EI\1\TO FCZEO LEONARD E TER M- MAQGET ATTORNEY 3,373,741 PLASTIC SPLINT James T. Hill, Bowie, Md., Donald R. Ingenito, Washington, D.C., and Fred Leonard, Bethesda, and Peter M. Margetis, Silver Spring, Md., assignors t the United States of America as represented by the Army Filed Mar. 19, 1965, Ser. No. 441,389 8 Claims. (Cl. 12890) the Secretary of ABSTRACT OF THE DISCLOSURE The invention described herein may be manufactured and-used by or for the Government for governmental purposes without the payment to us of any royalty thereon.
In the emergency treatment of broken bones, dislocations and sprains, splints are required to render the injured member immobile while the patient is being transferred to a hospital or other place for the necessary medical treatment. Splints also are used in the treatment of injuries such as sprains and dislocations in which a permanent cast is not required. In the particular instance of battle wounds and injuries sustained in inaccessible places, such as those sustained in skiing, hunting or mountain climbing accidents, it is desirable that the splint be light weight and compact. It is also desirable that the splint be applicable under adverse conditions of light and Weather. In addition, especially in the case of battle wounds, the splint should be capable of bearing a load so that the injured party may, after having the splint applied, leave the scene of the injury under his own power.
The emergency splints presently used by the Army are generally either basswood splints or wire ladder splints. Both of these splints are bulky and must be heavily padded before use. As opposed thereto, the splint of this invention, before application, is a unitary, flexible structure capable of being folded or rolled into a compact package and weighs approximately 0.9 pound.
It is accordingly an object of this invention to provide a unitary self-contained splint package.
It is another object of this invention to provide a lightweight compact splint.
It is further an object of this invention to provide a light weight load bearing splint.
These and other objects of the invention will be obvious from the following description of the invention with reference to the accompanying drawings wherein:
FIG. 1 is a perspective view of one embodiment of the invention;
FIG. 2 is a perspective view of the splint of the invention used in the treatment of a knee injury;
FIG. 3 is a perspective view of an embodiment of the invention employing a foam forming resin;
FIG. 4 is a perspective view of a splint for use on an injured jaw; and
FIG. 5 is a perspective view, partly cut away, of a packaged splint.
Broadly the objects of this invention are accomplished when the splint comprises a closed envelope containing at least two separate and distinct materials maintained separately, the materials when mixed being capable of forming a cured plastic resin composition. As will be described more fully below, blowing agents and reinforcice ing means may also be incorporated in the envelope when needed.
The essential characteristic to be considered in choosing the material used for the envelope is that it be insoluble in, non-reactive with and non-permeable to the materials used to form the cured resin. Suitable materials consist of most of the commercially available packaging films. Polystyrene and Pliofilm, however, which tend to be soluble in urethane systems containing tolylene diisocyanate therefore should not be used with such systems. The films can be heat scalable or capable of adhesive bonding and may either be single layers or laminated. Films which can be used either alone or in lamination are cellophane, cellulose acetate, polyvinylidene chloride, polyvinyl chloride, polypropylene, polyethylene and polyesters. A particularly good laminate consists of oriented polyestenpolyvinylidene chloride-polyethylene since the individual layers provide distinct advantages in the film. The polyester supplies toughness to resist tearing when the envelope is kneaded; the polyvinylidene chloride provides a water vapor barrier to protect water-sensitive isocyanate components and the polyethylene permits heat sealing. Aluminum foil also can be incorporated in a laminate to reduce water vapor permeability.
The resin systems usable in the invention are quite varied. The essential criteria in their choice being that they cure to form a hardened solid upon the mixture of the separate components of the system without the application of heat. Foam systems that do not require the application of heat from an external source to accomplish blowing are usable in certain embodiments of the invention. Broadly, polyester, epoxy and polyurethane resin systems have been found to be particularly effective in this invention.
According to the invention, the precursors of the cured resin are maintained physically separated in individual compartments in the splint envelope until the splint is to be formed at which time they are mixed, formed to shape and allowed to cure.
The precursors, depending upon the resin system used, may comprise the basic materials from which the cured resins are formed or they may be prepolymer or partial prepolymer systems.
For example, when a polyester resin system is used one compartment contains the uncured resin and a promoter, if necessary, and the other compartment could contain the catalyst. With epoxy resins one compartment contains the uncured resin and the other compartment the curing agent. With polyurethane foam systems one compartment contains a polyisocyanate and the other compartment contains a polyol resin, a blowing agent, a surfactant and catalyst.
A prepolymer system is one in which the polyisocyanate and polyol are permitted to react in advance, with the polyisocyanate being present in excess in the product. This product is in the first compartment and the second compartment contains blowing agent, surfactant and catalyst. In such a system, the amount of material in the second compartment is very small, being in the order of 1-10 parts of the mixture to parts prepolymer and permits the second compartment to be in the form of a capsule within the prepolymer compartment.
A quasi or partial prepolymer system is similar to the prepolymer system except that only part of the polyol is reacted with the polyisocyanate to form the product in the first compartment and the second compartment contains polyol resin in addition to the materials of the prepolymer system.
Polyester resins usable in this invention are those unsaturated polyester resins generally based on dibasic acids or anhydrides and dihydric alcohols which are capable a of crosslinking with vinylic monomers to form thermoset materials. Examples of suitable dibasic acids and anhydrides include maleic anhydride, phthalic anhydride, adipic acid, succinic acid and fumaric acid. Typical dihydric alcohols include ethylene, propylene, diethylene and dipropylene glycols. Polyhydroxyl alcohols such as glycerol and pentaerythritol can be used to introduce branching in the polyester chains. Monomers added to the resins which serve to reduce their viscosities and which are reactants in crosslinking of the resin include styrene, methyl methacrylate, diallyl phthalate and triallyl cyanurate. The type of resins defined above form the first component of a polyester system.
Catalysts or initiators are used to actuate the crosslinking process through a free radical mechanism which involves the opening of the double bonds of the polyester chain and/or the monomer. Typical catalysts include peroxides such as benzoyl and lauroyl peroxide and hydroperoxides such as cumene and tertbutyl hydroperoxide and methylethylketone peroxide.
Accelerators are used to promote release of free radicals and include metallic salts such as cobalt and manganese naphthenate, anilines such as diethyl and methyl aniline and mercaptans such as dodecyl mercaptan and mercaptoethanol.
The common epoxy resins are produced by the reaction of epoxy compounds with dihydro phenols, for example reacting epichlorodydrin with bisphenol A. In this invention only liquid resins can be used, commercial examples of which are Epon 815 and 828 available from Shell Chemical Corporation and ERL 2795 available from Union Carbide. These resins are contained in one compartment and the curing agent or catalyst which may be amines, anhydrides or acids is in the second compartment. In this invention catalysts, such as the polyfunctional aliphatic amines which cause rapid reaction, are required: examples of which are diethylene triamine and diethylamino propylamine.
With respect to the polyurethane foam systems described above, polyisocyanates useful in this application include 2,4-tolylene diisocyanate, 2,6-tolylene diisocyanate and mixtures of these isomers; p,p-diphenylmethane diisocyanate; m-phenylene diisocyanate; 1,5-naphthalene diisocyanate; hexamethyiene diisocyanate; dianisidine diisocyanate; polymethylene polyphenyl isocyanate; and diphenylmethane 4,4'-diisocyanate.
Polyol or polyhydroxy compounds usable in the above systems include ethylene and propylene oxide adducts of polyfunctional active hydrogen compounds such as glycerine, sorbitol, trimethylolpropane, ethylene diamine, sucrose, etc., and generally referred to as polyethers. Another class of polyhydroxy compounds usable in the above systems are the hydroxyl terminated polyesters made by the esterification of polybasic acids with polyhydric alcohols.
Blowing agents useful in this invention include water, which reacts with the isocyanate producing carbon dioxide, and other materials which generate a gas when mixed.
Catalysts useful in these reactions include amines, particularly tertiary amines, e.g., N-methyl morpholine, triethyl amine, triethyl diamine (l,4-diazobicyclo-(2,2,2)- octane): organometallic compounds are likewise useful as catalysts, e.g., stannous octoate, dibutyltin dilaurate, lead naphthenate, cobalt naphthenate, tributyl in methacrylate. Certain synergistic combinations of catalysts are known to the urethane foam industry and can be usefully employed in this application, e.g., organotin and tertiary amine combinations. Concentrations of these catalysts ranging between .1 and percent can be used, and this concentration may be varied to vary the reaction time.
Useful surfactants include organo silicon compounds such as dimethyl polysiloxane and polyalkylene ether copolymers. Commercial products used include Union Carbide Corporations L-520, L53l, General Electric Corportions XI -1066 and SF-1034 and Dow Cornings 113.
t These materials function to promote fine, uniform cell formation within the foam.
Polyurethane foam materials can be formed using these processes in a wide range of foam densities. Foam densities useful in this invention range from 4 to pounds per cubic foot.
In all of the above systems the material should be chosen so that the resin cures within a time suitable for the condition under which the splint is to be used. For use in battle wounds or emergency accident treatment, a rapid cure is essential and polyester or polyurethane systems that cure within 10 minutes are desirable. When used in hospitals or places where time of cure is not of the essence, epoxy systems, which have cure times in the order of hours, are suitable.
Referring now to FIG. 1, one embodiment of the invention consists of a closed flexible envelope 1, formed from a laminate of 3 mil polyethylene and 1 mil mylar heat sealed around the edge having two compartments 2 and 3 formed at one end thereof. The compartments may be formed by a weak heat seal across the width of the envelope or by a weak adhesive bond or by means which pinch off an area across the width of the envelope. The preferred embodiment employs split resilient cylinder separators 4 and 5 which engage folds 6 and 7 of the envelope formed around cylinders and 51. Each compartment contains a precursor of a cured polyester resin system or of a cured epoxy resin system.
The other portion of the envelope contains, coextensive therewith, a reinforcing mat 8. The mat is preferably made of 4 layers of woven fiberglass but other woven, knitted or matted textiles such as nylon, Dacron, cotton or Orlon may be used. The lower portion of the envelope has secured thereto thick flexible pad 9 which serves as padding to prevent irritation of the patient and also serves as insulation to protect the patent from the heat liberated during the curing process. Pad 9 can, for example, be made from A" flexible polyurethane foam adhesively bonded to the envelope by an adhesive on the foam.
In use, the separation between compartments 2 and 3 is removed by breaking the bond forming the separation or by removing separator 4 and the precursors in the two compartments are mixed thoroughly. After mixing is completed, the remaining separator 5 is removed and the contents worked uniformly into the remaining section of envelope 1 to impregnate mat 8 with the mixture. After the mat 8 has been impregnated with the resin, the split is placed in contact with the injured member, with the pad 9 contacting the body, and formed to the desired shape. The splint is then fastened in place by means of straps 10 as shown in FIG. 2.
Suitable precursor compositions for a polyester resin system are set forth below:
Example 1 Compartment 2:
Laminac 4110 g 200 Vibrin Promotor #3 ml 5 Compartment 3:
Benzoyl peroxide paste (50% in tricresyl phosphate) gm 4 Example 2 Compartment 2:
Epon 815 g- 200 Compartment 3:
Epon curing agent T-1 g 50 Both components are available from Shell Chemical Corporation, Epon 815 being a liquid epoxy resin with a viscosity of about 700 centipoise and an epoxide equivalent of 175-195 and the T-l curing agent being an aliphatic polyamine. Cure was sufiicient to yield a weight bearing splint after 4 hours.
The splint package used when a foam resin system is employed differs from that already described basically in that the mat 8 is not incorporated into the envelope.
As shown in FIG. 3, the envelope 1 has two compartments 2 and 3 formed at one end thereof by separators 4 and 5, each compartment containing a precursor of the foamed resin. The pad 9 is secured to envelope 1 up to the edge of compartment 3. The pad is equal in length to the whole envelope and that portion coextensive with compartments 2 and 3 has a strippable sheet 12 adhered thereto. In use, the precursors are mixed as described above until the mixture takes on a whitish appearance and there is a noticeable evolution of heat. The other separator is then removed and the foaming resin worked uniformly through the envelope 1. The backing 12 is removed and pad 9 is adhered to the portion of the envelope that previously formed compartments 2 and 3. The splint is now ready for application and is placed in contact with the injured member, shaped and fastened as described above.
Suitable precursor compositions, a polyurethane foam system, are as follows:
Example 3 Compartment 2:
Isofoam 15-A gm 150 Compartment 3:
Isofoam 15W gm- 113 Stannous octoate mg 9 Triethylene diamine mg 9 The Isofoam materials were obtained from the Isocyanate Products Co. and the above mixture yielded a weight bearing splint with a foam density of 18 pound/ft. six minutes after mixing of the precursors.
The above examples have been described with respect to a splint for a limb injury and the envelopes for such application are about 26" long and 8" wide. However, the splint of this invention can be made in different configurations for various uses. Referring now to FIG. 4 a splint package for a jaw injury is illustrated.
In this embodiment, the envelope 21 is formed into the shape shown with the central opening 22 heat sealed around the edges. A foam pad 23 of the same configuration as envelope 21 is adhered to one surface of the envelope 21. The envelope 21 contains a liquid prepolymer 24 having an excess of isocyanate and a blowing agent, catalyst, surfactant mixture is contained within rupturable capsule 25, The capsule can be formed of the same material as envelope 1. In use the capsule 25 is ruptured, the contents mixed with the prepolymer 24 until the mixture turns white and heat is evolved. The mixture is distributed evenly throughout the envelope and then applied with the subjects jaw in the central opening 22, formed to shape and then held in place with adhesive tape or tied by straps.
In the above splint approximately 50 grams of a liquid prepolymer containing excess polyisocyanate is contained in the envelope and the capsule contains 2 gms. of water, 2 gms. of triethylene diamine and 9 mg. of stannous octoate.
Before curing the splint, envelopes can be rolled into a compact cylinder and packaged in a tubular container 30 together with the adhesive or other type of straps 11 used to fasten the splints as shown in FIG. 5.
While this invention has been disclosed with respect to several embodiments thereof, the invention is not limited thereto and includes all modifications thereof within the scope of the following claims.
We claim:
1. A splint package comprising a flexible sealed envelope having a flexible pad attached to one face thereof substantially coextensive therewith, the interior of said envelope being divided into at least two compartments by removable separating means, a first compartment containing a first material and a second compartment containing a second material, said first and second materials being precursors of a cured resin system and which, when mixed, will cure without the application of external heat.
2. The splint package of claim 1 wherein the interior of said envelope is divided into three compartments, the third compartment containing, coextensive therewith, flexible reinforcing means and wherein said first and second materials are precursors of cured resin systems selected from the group consisting of polyester resins and epoxy resins.
3. The splint package of claim 2 wherein said reinforcing means is a woven fiberglass mat.
4. The splint package of claim 1 wherein said first and second materials are precursors of a foamed resin system and one of said materials contains a blowing agent.
5. The splint package of claim 1 wherein at least one of said removable separating means comprises a resilient member in clamping engagement with a fold across the width of said envelope.
6. The splint package of claim 1 wherein at least one of said separators comprises a rupturable capsule contained within one of said compartments.
7. The splint package of claim 1 wherein the interior of said envelope is divided into three compartments, said third compartment being substantially longer than the combined lengths of said first and second compartments and said flexible pad is attached to the face of said envelope coextensive with said third compartment.
8. The splint package of claim 7 wherein the flexible pad extends along the length of said first and second compartments and the portion of said pad coextensive therewith has an adhesive surface covered by a removable sheet.
References Cited UNITED STATES PATENTS 2,700,461 1/1955 Smith 20647 2,864,492 12/1958 Lappala 206-47 2,874,830 2/ 1959 Birmingham 206-47 RICHARD A. GAUDET, Primary Examiner. J. W. HINEY, Assistant Examiner.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US441389A US3373741A (en) | 1965-03-19 | 1965-03-19 | Plastic splint |
| GB12290/66A GB1146821A (en) | 1965-03-19 | 1966-03-21 | Improvements in or relating to surgical splints |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US441389A US3373741A (en) | 1965-03-19 | 1965-03-19 | Plastic splint |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3373741A true US3373741A (en) | 1968-03-19 |
Family
ID=23752690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US441389A Expired - Lifetime US3373741A (en) | 1965-03-19 | 1965-03-19 | Plastic splint |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3373741A (en) |
| GB (1) | GB1146821A (en) |
Cited By (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3643656A (en) * | 1969-06-16 | 1972-02-22 | Joseph V Young | Inflatable surgical cast |
| US3674021A (en) * | 1970-12-28 | 1972-07-04 | Harold I Snyder | Plastic bandage or splint |
| US3682179A (en) * | 1970-05-01 | 1972-08-08 | Jay A Firth | Hoof repair device |
| US3782390A (en) * | 1971-07-23 | 1974-01-01 | A Johnson | Pedicure prosthesis for the metatarsal arch of the foot |
| US3900024A (en) * | 1974-01-28 | 1975-08-19 | Leo E Lauber | Orthopedic cast and method of constructing same |
| US3905376A (en) * | 1971-07-23 | 1975-09-16 | Amos N Johnson | Pedicure prosthesis for the metatarsal arch of the foot |
| US3908644A (en) * | 1974-06-24 | 1975-09-30 | Allied Chem | Lightweight orthopedic cast material |
| US3923049A (en) * | 1974-06-28 | 1975-12-02 | Leo E Lauber | Orthopedic cast and method of constructing same |
| US3930496A (en) * | 1974-11-13 | 1976-01-06 | Gibbons Delamar J | Cast for broken limbs and method |
| US3935355A (en) * | 1971-12-28 | 1976-01-27 | Hans Georg Kuhn | Wrapping material |
| US4019506A (en) * | 1975-03-14 | 1977-04-26 | Peter Eschmann | Rigid supporting bandage and method for applying same |
| US4060075A (en) * | 1976-01-06 | 1977-11-29 | Alois Blomer | Splint and body-support device |
| US4240415A (en) * | 1978-12-18 | 1980-12-23 | WFR/Aquaplast Corp. | Orthopedic cast |
| US4300542A (en) * | 1979-12-17 | 1981-11-17 | Baron Howard C | Compression device for human limbs |
| US4306549A (en) * | 1979-02-01 | 1981-12-22 | Canie Joseph G | Splint-cast |
| US4327046A (en) * | 1979-12-07 | 1982-04-27 | Southern Research Institute | Method for producing a rigid, shaped mass support system |
| EP0057988A3 (en) * | 1981-02-09 | 1982-09-01 | Smith And Nephew Associated Companies P.L.C. | Bandages |
| US4374520A (en) * | 1980-09-11 | 1983-02-22 | American Hospital Supply Corporation | System and method for bandaging a patient |
| US4385024A (en) * | 1978-07-31 | 1983-05-24 | Tansill Horace A | Method for making a molded article from a curable material and a curing agent, the curing agent being in a container initially flexible and infrangible which is made frangible |
| US4411262A (en) * | 1978-04-21 | 1983-10-25 | Bayer Aktiengesellschaft | Constructional material |
| US4450833A (en) * | 1981-12-02 | 1984-05-29 | Brooks William R | Method of dimensioning a polyurethane foam bandage |
| US4483333A (en) * | 1982-06-01 | 1984-11-20 | Wrf/Aquaplast Corporation | Orthopedic cast |
| US4498467A (en) * | 1982-01-20 | 1985-02-12 | H. B. Kirkpatrick | Orthopedic cast, device and method for forming same and package therefor |
| US4570622A (en) * | 1981-12-31 | 1986-02-18 | Bayer Aktiengesellschaft | Constructional material |
| US4683877A (en) * | 1985-10-04 | 1987-08-04 | Minnesota Mining And Manufacturing Company | Orthopedic casting article and method |
| US4774937A (en) * | 1985-10-04 | 1988-10-04 | Minnesota Mining And Manufacturing Company | Curable resin coated sheet having reduced tack |
| US4777946A (en) * | 1985-11-20 | 1988-10-18 | Nakamura Brace Co., Ltd. | Patella brace |
| US4856502A (en) * | 1987-05-05 | 1989-08-15 | Minnesota Mining And Manufacturing Company | Curable resin coated sheets having reduced tack |
| US4888225A (en) * | 1985-10-04 | 1989-12-19 | Minnesota Mining And Manufacturing Company | Resin-impregnated foam materials and methods |
| US4928678A (en) * | 1989-08-11 | 1990-05-29 | Royce Medical Company | Soft-goods type, formable orthopaedic cast |
| US4946726A (en) * | 1985-10-04 | 1990-08-07 | Minnesota Mining And Manufacturing Company | Orthopedic splinting articles and methods |
| US4968542A (en) * | 1986-09-03 | 1990-11-06 | Minnesota Mining And Manufacturing Company | Curable material for semi-rigid resilient orthopedic support |
| US4996979A (en) * | 1989-10-13 | 1991-03-05 | Royce Medical Company | Soft-goods type, formable orthopaedic cast |
| US5002047A (en) * | 1986-09-03 | 1991-03-26 | Minnesota Mining And Manufacturing Company | Orthotic pads and methods |
| US5007418A (en) * | 1986-09-03 | 1991-04-16 | Minnesota Mining And Manufacturing Company | Resilient semi-rigid orthopedic support devices |
| USRE33727E (en) * | 1980-09-11 | 1991-10-29 | Baxter International, Inc. | Bandage frame |
| US5139015A (en) * | 1991-10-21 | 1992-08-18 | Kevin Morneau | Knee support wrap for lifting weights |
| US5195945A (en) * | 1985-10-04 | 1993-03-23 | Minnesota Mining And Manufacturing Company | Orthotic pads and methods |
| US5203764A (en) * | 1985-10-04 | 1993-04-20 | Minnesota Mining And Manufacturing Company | Foam pads useful in wound management |
| US6007505A (en) * | 1998-06-02 | 1999-12-28 | Royce Medical Company | Tractable orthopaedic splint or support |
| US6231533B1 (en) | 1999-05-21 | 2001-05-15 | Ppg Industries Ohio, Inc. | Orthopedic splinting article |
| US6461317B1 (en) | 1998-06-02 | 2002-10-08 | Royce Medical Company | Water hardenable compositions for splints and braces |
| US6673727B2 (en) | 2001-02-01 | 2004-01-06 | Ebi, L.P. | Orthopedic casts with controlled flexibility |
| US6695801B1 (en) | 2001-12-14 | 2004-02-24 | Russ Toronto | Form-in-place foam orthopedic splint system |
| US20040171975A1 (en) * | 2001-02-01 | 2004-09-02 | Morris Roy A. | Casting aid and methods of forming casts |
| US20040186353A1 (en) * | 2001-08-10 | 2004-09-23 | Palermo Thomas J | Vascular retractor and methods of using same |
| US20060079819A1 (en) * | 2004-10-13 | 2006-04-13 | Bsn Medical, Inc. | Orthopedic splint |
| US7179242B2 (en) | 2003-08-01 | 2007-02-20 | Belzidsky Hugues C | Method of treating deep vein thrombosis |
| US20100233417A1 (en) * | 2006-06-12 | 2010-09-16 | Concrete Canvas Limited | Impregnated fabric |
| US20150282975A1 (en) * | 2014-04-07 | 2015-10-08 | Lawrence D. Herzman | Orthopedic Cast |
| US9187902B2 (en) | 2011-11-01 | 2015-11-17 | Cortex Composites, Llc | Nonwoven cementitious composite for in-situ hydration |
| US9987186B1 (en) * | 2013-12-10 | 2018-06-05 | Allie Lynch | Splinted compression bandage |
| US10167635B2 (en) | 2011-11-01 | 2019-01-01 | Cortex Composites, Inc. | Nonwoven cementitious composite for In-Situ hydration |
| US10221569B2 (en) | 2011-11-01 | 2019-03-05 | Cortex Composites, Inc. | Cementitious composite constituent relationships |
| FR3077480A1 (en) * | 2018-02-07 | 2019-08-09 | Elodie Vlamynck | ORTHESIS FOR STABILIZING AT LEAST ONE BODY SEGMENT, PACKAGING DEVICE FOR PREPARING A THERMOSETTING RESIN AND KIT THEREOF |
| FR3077575A1 (en) * | 2018-07-13 | 2019-08-09 | Elodie Vlamynck | PACKAGING DEVICE FOR PREPARING A THERMOSETTING RESIN AND KIT THEREOF |
| US10435859B2 (en) | 2015-11-05 | 2019-10-08 | Cortex Composites, Inc. | Cementitious composite mat |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19754560A1 (en) * | 1997-12-09 | 1999-06-10 | Wws Ideen Aus Pu Gmbh | Orthopedic device for supporting e.g. knee, elbow joint |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2700461A (en) * | 1952-07-19 | 1955-01-25 | Davis & Geck Inc | Article of manufacture |
| US2864492A (en) * | 1953-12-23 | 1958-12-16 | Bjorksten Res Lab Inc | Body of polymerizable material containing catalyst and carrier |
| US2874830A (en) * | 1956-01-30 | 1959-02-24 | Jr William G Birmingham | Packaging and mixing or processing kit |
-
1965
- 1965-03-19 US US441389A patent/US3373741A/en not_active Expired - Lifetime
-
1966
- 1966-03-21 GB GB12290/66A patent/GB1146821A/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2700461A (en) * | 1952-07-19 | 1955-01-25 | Davis & Geck Inc | Article of manufacture |
| US2864492A (en) * | 1953-12-23 | 1958-12-16 | Bjorksten Res Lab Inc | Body of polymerizable material containing catalyst and carrier |
| US2874830A (en) * | 1956-01-30 | 1959-02-24 | Jr William G Birmingham | Packaging and mixing or processing kit |
Cited By (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3643656A (en) * | 1969-06-16 | 1972-02-22 | Joseph V Young | Inflatable surgical cast |
| US3682179A (en) * | 1970-05-01 | 1972-08-08 | Jay A Firth | Hoof repair device |
| US3674021A (en) * | 1970-12-28 | 1972-07-04 | Harold I Snyder | Plastic bandage or splint |
| US3905376A (en) * | 1971-07-23 | 1975-09-16 | Amos N Johnson | Pedicure prosthesis for the metatarsal arch of the foot |
| US3782390A (en) * | 1971-07-23 | 1974-01-01 | A Johnson | Pedicure prosthesis for the metatarsal arch of the foot |
| US3935355A (en) * | 1971-12-28 | 1976-01-27 | Hans Georg Kuhn | Wrapping material |
| US3900024A (en) * | 1974-01-28 | 1975-08-19 | Leo E Lauber | Orthopedic cast and method of constructing same |
| US3908644A (en) * | 1974-06-24 | 1975-09-30 | Allied Chem | Lightweight orthopedic cast material |
| US3923049A (en) * | 1974-06-28 | 1975-12-02 | Leo E Lauber | Orthopedic cast and method of constructing same |
| US3930496A (en) * | 1974-11-13 | 1976-01-06 | Gibbons Delamar J | Cast for broken limbs and method |
| US4019506A (en) * | 1975-03-14 | 1977-04-26 | Peter Eschmann | Rigid supporting bandage and method for applying same |
| US4060075A (en) * | 1976-01-06 | 1977-11-29 | Alois Blomer | Splint and body-support device |
| US4411262A (en) * | 1978-04-21 | 1983-10-25 | Bayer Aktiengesellschaft | Constructional material |
| US4385024A (en) * | 1978-07-31 | 1983-05-24 | Tansill Horace A | Method for making a molded article from a curable material and a curing agent, the curing agent being in a container initially flexible and infrangible which is made frangible |
| US4240415A (en) * | 1978-12-18 | 1980-12-23 | WFR/Aquaplast Corp. | Orthopedic cast |
| US4306549A (en) * | 1979-02-01 | 1981-12-22 | Canie Joseph G | Splint-cast |
| US4327046A (en) * | 1979-12-07 | 1982-04-27 | Southern Research Institute | Method for producing a rigid, shaped mass support system |
| US4300542A (en) * | 1979-12-17 | 1981-11-17 | Baron Howard C | Compression device for human limbs |
| US4374520A (en) * | 1980-09-11 | 1983-02-22 | American Hospital Supply Corporation | System and method for bandaging a patient |
| USRE33727E (en) * | 1980-09-11 | 1991-10-29 | Baxter International, Inc. | Bandage frame |
| EP0057988A3 (en) * | 1981-02-09 | 1982-09-01 | Smith And Nephew Associated Companies P.L.C. | Bandages |
| US4427003A (en) | 1981-02-09 | 1984-01-24 | Smith & Nephew Associated Companies Ltd. | Bandages |
| US4450833A (en) * | 1981-12-02 | 1984-05-29 | Brooks William R | Method of dimensioning a polyurethane foam bandage |
| US4570622A (en) * | 1981-12-31 | 1986-02-18 | Bayer Aktiengesellschaft | Constructional material |
| US4498467A (en) * | 1982-01-20 | 1985-02-12 | H. B. Kirkpatrick | Orthopedic cast, device and method for forming same and package therefor |
| US4483333A (en) * | 1982-06-01 | 1984-11-20 | Wrf/Aquaplast Corporation | Orthopedic cast |
| US4774937A (en) * | 1985-10-04 | 1988-10-04 | Minnesota Mining And Manufacturing Company | Curable resin coated sheet having reduced tack |
| AU579023B2 (en) * | 1985-10-04 | 1988-11-10 | Minnesota Mining And Manufacturing Company | Orthopedic casting article and method |
| US4888225A (en) * | 1985-10-04 | 1989-12-19 | Minnesota Mining And Manufacturing Company | Resin-impregnated foam materials and methods |
| US5203764A (en) * | 1985-10-04 | 1993-04-20 | Minnesota Mining And Manufacturing Company | Foam pads useful in wound management |
| US4946726A (en) * | 1985-10-04 | 1990-08-07 | Minnesota Mining And Manufacturing Company | Orthopedic splinting articles and methods |
| US4683877A (en) * | 1985-10-04 | 1987-08-04 | Minnesota Mining And Manufacturing Company | Orthopedic casting article and method |
| US5195945A (en) * | 1985-10-04 | 1993-03-23 | Minnesota Mining And Manufacturing Company | Orthotic pads and methods |
| US4777946A (en) * | 1985-11-20 | 1988-10-18 | Nakamura Brace Co., Ltd. | Patella brace |
| US4968542A (en) * | 1986-09-03 | 1990-11-06 | Minnesota Mining And Manufacturing Company | Curable material for semi-rigid resilient orthopedic support |
| US5002047A (en) * | 1986-09-03 | 1991-03-26 | Minnesota Mining And Manufacturing Company | Orthotic pads and methods |
| US5007418A (en) * | 1986-09-03 | 1991-04-16 | Minnesota Mining And Manufacturing Company | Resilient semi-rigid orthopedic support devices |
| US4856502A (en) * | 1987-05-05 | 1989-08-15 | Minnesota Mining And Manufacturing Company | Curable resin coated sheets having reduced tack |
| WO1991001700A1 (en) * | 1989-08-11 | 1991-02-21 | Royce Medical Company | Soft-goods type, formable orthopaedic cast |
| US4928678A (en) * | 1989-08-11 | 1990-05-29 | Royce Medical Company | Soft-goods type, formable orthopaedic cast |
| US4996979A (en) * | 1989-10-13 | 1991-03-05 | Royce Medical Company | Soft-goods type, formable orthopaedic cast |
| WO1991005526A1 (en) * | 1989-10-13 | 1991-05-02 | Royce Medical Company | Soft-goods type, formable orthopeadic cast |
| US5139015A (en) * | 1991-10-21 | 1992-08-18 | Kevin Morneau | Knee support wrap for lifting weights |
| US6007505A (en) * | 1998-06-02 | 1999-12-28 | Royce Medical Company | Tractable orthopaedic splint or support |
| US6461317B1 (en) | 1998-06-02 | 2002-10-08 | Royce Medical Company | Water hardenable compositions for splints and braces |
| WO2000033772A1 (en) | 1998-12-04 | 2000-06-15 | Royce Medical Products | Water hardenable compositions for splints and braces |
| US6231533B1 (en) | 1999-05-21 | 2001-05-15 | Ppg Industries Ohio, Inc. | Orthopedic splinting article |
| US6673727B2 (en) | 2001-02-01 | 2004-01-06 | Ebi, L.P. | Orthopedic casts with controlled flexibility |
| US20040171975A1 (en) * | 2001-02-01 | 2004-09-02 | Morris Roy A. | Casting aid and methods of forming casts |
| US20040186353A1 (en) * | 2001-08-10 | 2004-09-23 | Palermo Thomas J | Vascular retractor and methods of using same |
| US7204817B1 (en) | 2001-12-14 | 2007-04-17 | Nuplyonix, L.L.C. | Form-in-place foam orthopedic splint system |
| US6695801B1 (en) | 2001-12-14 | 2004-02-24 | Russ Toronto | Form-in-place foam orthopedic splint system |
| US7179242B2 (en) | 2003-08-01 | 2007-02-20 | Belzidsky Hugues C | Method of treating deep vein thrombosis |
| US20060079819A1 (en) * | 2004-10-13 | 2006-04-13 | Bsn Medical, Inc. | Orthopedic splint |
| US20100233417A1 (en) * | 2006-06-12 | 2010-09-16 | Concrete Canvas Limited | Impregnated fabric |
| US8287982B2 (en) * | 2006-06-12 | 2012-10-16 | Concrete Canvas Limited | Impregnated fabric |
| US11008756B2 (en) | 2011-11-01 | 2021-05-18 | Cortex Composites, Inc. | Nonwoven cementitious composite for in-situ hydration |
| US11428006B2 (en) | 2011-11-01 | 2022-08-30 | Cortex Composites, Inc. | Cementitious composite constituent relationships |
| US9187902B2 (en) | 2011-11-01 | 2015-11-17 | Cortex Composites, Llc | Nonwoven cementitious composite for in-situ hydration |
| US9567750B2 (en) | 2011-11-01 | 2017-02-14 | Cortex Composites, Inc. | Nonwoven cementitious composite for in-situ hydration |
| US10167635B2 (en) | 2011-11-01 | 2019-01-01 | Cortex Composites, Inc. | Nonwoven cementitious composite for In-Situ hydration |
| US10221569B2 (en) | 2011-11-01 | 2019-03-05 | Cortex Composites, Inc. | Cementitious composite constituent relationships |
| US11098486B2 (en) | 2011-11-01 | 2021-08-24 | Cortex Composites, Inc. | Cementitious composite constituent relationships |
| US9987186B1 (en) * | 2013-12-10 | 2018-06-05 | Allie Lynch | Splinted compression bandage |
| US20150282975A1 (en) * | 2014-04-07 | 2015-10-08 | Lawrence D. Herzman | Orthopedic Cast |
| US10435859B2 (en) | 2015-11-05 | 2019-10-08 | Cortex Composites, Inc. | Cementitious composite mat |
| US10870964B2 (en) | 2015-11-05 | 2020-12-22 | Cortex Composites, Inc. | Cementitious composite mat |
| FR3077480A1 (en) * | 2018-02-07 | 2019-08-09 | Elodie Vlamynck | ORTHESIS FOR STABILIZING AT LEAST ONE BODY SEGMENT, PACKAGING DEVICE FOR PREPARING A THERMOSETTING RESIN AND KIT THEREOF |
| FR3077575A1 (en) * | 2018-07-13 | 2019-08-09 | Elodie Vlamynck | PACKAGING DEVICE FOR PREPARING A THERMOSETTING RESIN AND KIT THEREOF |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1146821A (en) | 1969-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3373741A (en) | Plastic splint | |
| US4475543A (en) | Lumbosacral brace | |
| EP0061642B1 (en) | Casting or splinting package and method of constructing same | |
| AU599202B2 (en) | Orthopedic splinting articles and methods | |
| US4996979A (en) | Soft-goods type, formable orthopaedic cast | |
| US4309990A (en) | Foam medical cast | |
| US3908644A (en) | Lightweight orthopedic cast material | |
| JP2821475B2 (en) | Surgical bandage and method of making | |
| EP0305175B1 (en) | Curable Compositions | |
| JPS58175561A (en) | Material for orthodontic surgery | |
| US4928678A (en) | Soft-goods type, formable orthopaedic cast | |
| US4841958A (en) | Nonwoven orthopedic casting materials with apertures | |
| US7204817B1 (en) | Form-in-place foam orthopedic splint system | |
| AU1103583A (en) | Cold water curable orthopedic cast | |
| IE54493B1 (en) | Cold water curable orthopedic cast | |
| AR010463A2 (en) | FLEXIBLE FOAM COMPOSITION | |
| WO2002045630A2 (en) | Custom-formable knee immobilizer product, knee immobilizer and method | |
| GB2288541A (en) | Orthopaedic support | |
| US20060079819A1 (en) | Orthopedic splint | |
| ES522803A0 (en) | "A METHOD FOR PREPARING A RIGID FOAM DERIVED FROM ISOCYANATE" | |
| JP5174316B2 (en) | Simple lightweight cast | |
| RU32393U1 (en) | MEDICAL QUICK-CURING MATERIAL | |
| US4676234A (en) | Moisture-hardenable bandaging materials | |
| JP3940763B2 (en) | Auxiliary tool for body fixing material | |
| JPH069746A (en) | Composition |